1/22, 4:55 AM (Source: TeleTrader)
more TeleTrader news

FDA approves remdesivir for some non-hospitalized patients

The United States Food and Drug Administration (FDA) expanded its approval of Gilead Sciences antiviral drug Veklury (remdesivir) to treat some non-hospitalized COVID-19 patients.

The agency said the drug can be given to people 12 years and older that have mild-to-moderate symptoms and a high risk of hospitalization.

The FDA first approved remdesivir in October 2020 but limited it to hospitalized coronavirus patients.

Baha Breaking the News (BBN) / NP